Drug prevention of recurrence of atrial fibrillation in Progress.docVIP

 PAGE \* MERGEFORMAT 12 Drug prevention of recurrence of atrial fibrillation in Progress [Keywords:] Progress in drug prevention recurrence of atrial fibrillation Atrial fibrillation (AF) treatment goal is to [1,2]: the cardioversion of atrial fibrillation and maintain sinus rhythm; can not restore and maintain sinus rhythm when the ventricular rate control; prevention of thrombosis. Cardioversion of atrial fibrillation and prevention of atrial fibrillation recurrence and the primary treatment strategy. fibrillation to sinus rhythm switch (sinus rhythm) is a short-term treatment goals, long-term objective is to maintain sinus rhythm. As convenient oral medication, no special equipment and technical conditions , drug prevention recurrence of atrial fibrillation is still the main method. After the research and clinical practice, drug prevention of recurrent AF has made great progress. 1 anti-arrhythmic drugs Recurrence of paroxysmal atrial fibrillation or atrial fibrillation with obvious symptoms, and can tolerate antiarrhythmic drug therapy to prevent recurrence of atrial fibrillation in patients with primary indications for treatment. China Fibrillation Treatment Proposed Recommendation [1]: the symptoms of atrial fibrillation work and life of the drug of choice in patients with treatment to maintain sinus rhythm, the main consideration safety of the drug; at the beginning of anti-arrhythmic drug therapy before the first treatment of atrial fibrillation induced factors or reversible cause; and application of antiarrhythmic drugs to maintain sinus law, can prevent atrial fibrillation caused by tachycardia cardiomyopathy; some patients with atrial fibrillation episodes, and less well tolerated, can be considered anti-arrhythmic drugs results of successful treatment; of atrial fibrillation in selected patient started antiarrhythmic drug therapy is appropriate. The drug of choice is important to note when their heart disease, drug-induced arrhythmias